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Abstract
Collagen is modified by hydroxylation and glycosylation of hydroxylysine residues. This glycosylation is initiated by the b1,O
galactosyltransferases GLT25D1 and GLT25D2. The structurally similar protein cerebral endothelial cell adhesion molecule
CEECAM1 was previously reported to be inactive when assayed for collagen glycosyltransferase activity. To address the
cause of the absent galactosyltransferase activity, we have generated several chimeric constructs between the active human
GLT25D1 and inactive human CEECAM1 proteins. The assay of these chimeric constructs pointed to a short central region
and a large C-terminal region of CEECAM1 leading to the loss of collagen galactosyltransferase activity. Examination of the
three DXD motifs of the active GLT25D1 by site-directed mutagenesis confirmed the importance of the first (amino acids
166–168) and second motif (amino acids 461–463) for enzymatic activity, whereas the third one was dispensable. Since the
second DXD motif is incomplete in CEECAM1, we have restored the motif by introducing the substitution S461D. This
change did not restore the activity of the C-terminal region, thereby showing that additional amino acids were required in
this C-terminal region to confer enzymatic activity. Finally, we have introduced the substitution Q471R-V472M-N473Q-
P474V in the CEECAM1-C-terminal construct, which is found in most animal GLT25D1 and GLT25D2 isoforms but not in
CEECAM1. This substitution was shown to partially restore collagen galactosyltransferase activity, underlining its importance
for catalytic activity in the C-terminal domain. Because multiple mutations in different regions of CEECAM1 contribute to the
lack of galactosyltransferase activity, we deduced that CEECAM1 is functionally different from the related GLT25D1 protein.
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Introduction
Collagen undergoes several post-translational modifications
before formation of a right-handed triple helix in the endoplasmic
reticulum. These modifications include the hydroxylation of
selected proline [1] and lysine [2] residues. Thereafter, a portion
of hydroxylysine (Hyl) residues are further modified by the
addition of carbohydrates, forming the disaccharide Glc(a1-
2)Gal(b1-O)Hyl [3,4]. The extent of hydroxylation and glycosyl-
ation depends on the type of collagen and their tissue distribution.
The formation of hydroxyproline is essential for the thermal
stability of the collagen triple helix [5]. Lysyl hydroxylation is
important for the cross-linking of collagen fibrils and acts as
substrate for glycosylation reactions. The importance of collagen
post-translational modifications is reflected by the diseases
associated to defective collagen modifications. Mutations in prolyl
3-hydroxylase and in the lysyl hydroxylase genes lead to various
forms of skeletal dysplasia [6,7,8,9].
Whereas the roles of proline and lysine hydroxyllation in
collagen biology are well established, the functional relevance of
collagen glycosylation is presently unclear. Recently, we have
identified the two genes GLT25D1 and GLT25D2 as encoding
collagen galactosyltransferase (ColGalT) enzymes [10]. RNA
interference studies in Caenorhabditis elegans have shown that the
inactivation of the lysyl hydroxylase gene let-268 yields a lethal
phenotype related to abnormal collagen type-IV secretion [11,12].
Similarly, the inactivation of the D2045.9 gene, the putative
ortholog to human GLT25D1 and GLT25D2, is associated to
growth defects and multiple morphologic abnormalities [13,14].
The sequences of the GLT25D1 and GLT25D2 proteins were
found to be strongly similar to the cerebral endothelial cell
adhesion molecuzle (CEECAM1) protein [15]. However, in spite
of the strong structural conservation, CEECAM1 was found to be
inactive when assayed for collagen glycosyltransferase activity [10].
Although several types of collagen acceptors have been tested, it
could not be excluded that CEECAM1 only recognizes specific
substrates. Alternatively, the claimed localization of CEECAM1 at
the surface of endothelial cells [15] suggests that the protein does
not function as a glycosyltransferase like GLT25D1 and
GLT25D2 proteins. The CEECAM1 protein could be enzymat-
ically inactive as collagen glycosyltransferase because of point
mutations introduced during evolution. The polymorphism of
ABO blood group glycosyltransferases [16] or the inactive form of
the a1,3 galactosyltransferase gene in primate genomes [17] are
typical examples of such lost glycosyltransferase activities.
In the present work, we investigate the rationale for the lack of
ColGalT activity in the CEECAM1 protein by domain swapping
and single point mutation. By permutation with portions of the
active GLT25D1 galactosyltransferase, the production of
GLT25D1-CEECAM1 chimeric proteins enables the identifica-
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activity. In parallel, this approach allows narrowing down the
regions of GLT25D1 that are essential for the catalytic activity.
Results
The CEECAM1 protein is structurally similar to the ColGalT
enzymes GLT25D1 and GLT25D2. The comparison of the three
polypeptides shows 55% sequence identity between human
CEECAM1 and human GLT25D1 and 50% between human
CEECAM1 and human GLT25D2 [10]. The three proteins also
share the same putative conformation and domain organization as
predicted by the PROMALS3D algorithm [18] (Fig. 1). To further
compare the three proteins, we aligned GLT25D1, GLT25D2 and
CEECAM1 with known protein structures using the pdb70
database and HHpred tool (http://toolkit.tuebingen.mpg.de/
hhpred) [19]. This search pointed to a potential structural
similarity of the three proteins with the chondroitin polymerase
from Escherichia coli (PDB ID: 2z86). The region ranging from
amino acids 24 to 466 of human GLT25D1 produced a hit with
an E-value of 6.2E-09 and P-value of 2.7E-13. This bacterial
chondroitin polymerase belongs to the CAZY GT2 family of
glycosyltransferases and contains two functional domains adopting
a glycosyltransferase GT-A fold [20]. Such a binary structure is
supposedly adopted by the GLT25D1, GLT25D2 and CEE-
CAM1 proteins as also noted by Liefhebber et al. [21]. Based on
this prediction, the GLT25D1, GLT25D2 and CEECAM1
proteins can be parted into three structural domains: a N-terminal
domain of about 230 amino acids, a central domain of about 110
amino acids and a C-terminal domain of about 280 amino acids
(Fig. 1).
To identify the molecular basis for the lack of collagen
glycosyltransferase activity in CEECAM1, we constructed chime-
ric proteins between GLT25D1 and CEECAM1 based on the
Figure 1. Structural prediction of GLT25D1, GLT25D2 and CEECAM1 proteins. The protein sequences of human GLT25D1 (Swiss-
Prot:Q8NBJ5), GLT25D2 (Swiss-Prot:Q81IYK4) and CEECAM1 (Swiss-Prot:Q5T4B2) were aligned using the PROMALS3D program. The sequences were
analyzed and separated in two closely related groups, the first one with GLT25D1-D2 and the second one with CEECAM1, as determined with an
identity threshold of 0.6. The secondary structure predictions are marked by shaded blocks, with light grey representing a-helices and dark grey b-
strands. The predicted N-terminal, central and C-terminal domains are demarcated by vertical lines. The DXD motifs are underlined and marked in
bold. The region ranging from amino acids 24 to 466 of human GLT25D1 structurally related to the Escherichia coli chondroitin polymerase (PDB ID:
2z86) is marked with a horizontal line above the sequences.
doi:10.1371/journal.pone.0029390.g001
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chimeras were named CEECAM1-Nter, CEECAM1-Mid and
CEECAM1-Cter (Fig. 2). The chimeric proteins were Flag-tagged
at their N-terminus and expressed in Sf9 cells as recombinant
baculoviruses. The amount of recombinant proteins present in Sf9
cell lysates was monitored by Western blotting using an anti-Flag
antibody and ColGalT activity was assayed towards denatured
bovine collagen type I. The CEECAM1 and CEECAM1-Nter
proteins were expressed as two glycoforms, whereas the other
chimeric proteins expressed as a single band (Fig. 3). The
CEECAM1-Nter construct yielded the same ColGalT activity as
the GLT25D1 enzyme, showing that the N-terminal domain of
CEECAM1 does not contribute to the absence of glycosyltrans-
ferase activity. By contrast, the constructs including either the
central or the C-terminal domain of CEECAM1 did not show any
ColGalT activity (Fig. 3).
To delineate more precisely the regions of CEECAM1 and
GLT25D1 that are essential for enzymatic activity, we have
produced four additional chimeric constructs for the central
domain and five additional constructs for the C-terminal domain.
Figure 2. Schematic representation of chimeric GLT25D1-CEECAM1 constructs. Segments of GLT25D1 and CEECAM1 are marked in light
grey and dark grey, respectively. The boundaries of each segment are given by the amino acid positions in the GLT25D1 protein. The Flag tag is
shown with a white box at the N-terminus of each construct.
doi:10.1371/journal.pone.0029390.g002
Figure 3. ColGalT activity of GLT25D1, CEECAM1 and chimeric constructs. Values represent the mean and S.E.M. of at least four
independent assays per construct. The mock sample indicates the activity measured in Sf9 cells infected with an empty baculovirus. The protein
expression of each construct is shown at the top of each bar as performed by Western blotting using an anti-Flag tag antibody.
doi:10.1371/journal.pone.0029390.g003
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CEECAM1 central domain, only the construct, in which the
stretch between amino acids 232 and 282 of GLT25D1 was
replaced by the corresponding stretch of CEECAM1 (named
CEECAM1-MidC), was found to be enzymatically active, yet with
decreased ColGalT activity to 32% of wildtype GLT25D1 levels
(Fig. 3). The analysis of these four chimeric constructs delimitated
a CEECAM1 stretch of 63 amino acids that caused the loss of the
enzymatic activity when introduced into GLT25D1. The
comparison of GLT25D1, GLT25D2 and CEECAM1 protein
sequences from different animal genomes showed that this stretch
corresponds to a strongly conserved sequence region (Fig. 4A).
Within this stretch of 63 amino acids, only six conserved residues
within GLT25D1 and GLT25D2 isoforms were found to be
different in CEECAM1.
To study the impact of the C-terminal domain on ColGalT
activity, five chimeric constructs encompassing parts of the
CEECAM1 C-terminal domain in GLT25D1 (Fig. 2) were
expressed in Sf9 cells and assayed for enzymatic activity. This
analysis pointed to a large portion of the C-terminal domain as
being involved in the catalysis of the ColGalT reaction. In fact,
only the GLT25D1 stretch between amino acids 342 and 414 was
replaceable for enzymatic activity, as shown by the partially active
construct CEECAM1-CterC (Fig. 3). The examination of the C-
terminal domain of GLT25D1, GLT25D2 and CEECAM1 from
multiple animal species revealed 26 amino acid residues strongly
conserved in GLT25D1 and GLT25D2 but not in CEECAM1. Of
interest, two DXD motifs are included among these diverging
amino acids (Fig. 4B).
The presence of DXD motifs is typical for glycosyltransferases
utilizing nucleotide-activated sugars as donor substrates. Such
DXD motifs are usually involved in the binding of the nucleotide
diphosphate moiety through Mn
2+ chelation [22]. The collagen
galactosyltransferases GLT25D1 and GLT25D2 include three
DXD motifs and one related EDD motif (Fig. 1). The EDD and
one DXD motifs are also conserved in CEECAM1, whereas two
C-terminally localized DXD motifs are missing in CEECAM1.
This suggests that the C-terminal DXD motifs may be important
for the activity of the GLT25D1, considering their absence in the
enzymatically inactive CEECAM1 protein. To determine the
importance of the DXD motifs on the activity of GLT25D1, we
have produced mutant forms of GLT25D1 lacking each of these
three motifs. The mutant GLT25D1 proteins mainly yielded two
glycoforms (Fig. 5), although this pattern was not seen in all
expressed samples. The substitution D166A-D168A led to an
inactive protein, thus establishing the importance of the first DXD
motif for the ColGalT activity. Note worthily, this DXD motif is
also found in the N-terminal domain of CEECAM1. The second
DXD motif of GLT25D1, found at D461-D463, was also essential
to the ColGalT activity, since its mutation yielded an inactive
GLT25D1 protein (Fig. 5). By contrast, the last DXD motif of
GLT25D1 at D585-D587 was dispensable for the ColGalT
activity (Fig. 5).
As noted in our domain swapping experiments, a portion of the
CEECAM1 central domain abolished the enzymatic activity when
replacing the GLT25D1 stretch encompassing amino acids 280 to
342 (Fig. 3). In an attempt to isolate amino acids in this central
domain that are important for this enzyme activity, we replaced
the residues P292 and D336 in GLT25D1 by the corresponding
residues found in CEECAM1, thereby yielding the substitutions
P292N and D336S (Fig. 4). These two residues were selected
because they are strictly conserved in animal GLT25D1 and
GL25D2 isoforms. In addition, P292 may be involved in making a
critical twist in the polypeptide structure. The expression of the
two P292N and D336S GLT25D1 mutants showed that these two
substitutions only lightly decreased ColGalT activity, thereby
speaking against a critical involvement of these amino acids in the
inactivity of CEECAM1 (Fig. 5).
The comparison between the C-terminal domain of GLT25D1,
GLT25D2 and CEECAM1 isoforms from various animal
genomes pointed to 26 amino acids diverging between GLT25D1
and GLT25D2 on the one hand and CEECAM1 on the other
hand (Fig. 4). As shown here above, the C-terminal domain
includes an essential DXD motif that is not found in CEECAM1.
We chose to introduce this DXD motif in CEECAM1 to
determine if this change could restore the ColGalT activity in
the inactive chimeric construct CEECAM1-CterB (Fig. 2). To this
end, the S461D substitution was engineered and the resulting
CEECAM1-CterB[S461D] construct assayed for enzymatic activ-
ity. This test showed that the S461D substitution was insufficient to
restore ColGalT activity (Fig. 6). Another strictly conserved stretch
found in GLT25D1 and GLT25D2 but absent in CEECAM1 is
located just downstream of the D461–D463 DXD motif. This
stretch begins at R471 and reads RMQV whereas it corresponds
to a QVNP sequence in CEECAM1 (Fig. 4). We have added the
substitution Q471R-V472M-N473Q-P474V in the CEECAM1-
CterB[S461D] construct, yielding CEECAM1-
CterB[S461D][RMQV]. This new mutant form showed a
partially restored ColGalT activity (Fig. 6), thus demonstrating
the importance of this stretch for the enzymatic activity.
Finally, we determined the apparent Km and Vmax parameters
of the partially active chimeric constructs CEECAM1-MidC and
CEECAM1-CterC to assess whether the decreased activity can be
related to altered interaction with the substrates. This kinetic
analysis showed that the low ColGalT activity of CEECAM1-
MidC was due to decreased Vmax (Table 1), suggesting that the
central domain is important to maintain a normal reaction rate.
By contrast, the analysis of the CEECAM1-CterC showed normal
Vmax values but increased Km values for both donor and acceptor
substrates (Table 1). This finding supports the idea that the C-
terminal domain is important for the binding to UDP-Gal and to
collagen.
Discussion
The present study demonstrates that the inactivity of CEE-
CAM1 as a ColGalT is related to sequence variations in two
distinct regions of the protein. Based on the analysis of chimeric
constructs between the inactive CEECAM1 and the active
GLT25D1 proteins, the study also enabled the identification of
structural motifs essential to the ColGalT activity. The recombi-
nant GLT25D1, CEECAM1 and chimeric proteins tested were
expressed to similar levels in Sf9 insect cells and did not yield
insoluble aggregates. The resulting uniform expression patterns
enabled the functional comparison of all constructs described in
the study.
The N-terminal domain of GLT25D1 and CEECAM1 were
interchangeable without losing the galactosyltransferase activity,
which did not mean that this domain was dispensable for the
enzymatic activity. In fact, the DXD motif in this domain was
shown to be essential to the activity of GLT25D1. Since the N-
terminal domain of CEECAM1 could yield an active chimeric
protein when combined with GLT25D1, the experiment showed
that both proteins are structurally closely related and that such
chimeric constructs are neither instable nor inactive per se. The N-
terminal domain of GLT25D1, GLT25D2 and CEECAM1 also
shared structural similarity with glycosyltransferases like the
polypeptide N-acetylgalactosaminyltransferases-2, -10 (CAZY
Structure-Function Analysis of GLT25D1
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EXTL2 (CAZY family GT64) [23,24,25], indicating that the
sequence context around the first DXD motif is suitable for an
interaction with Mn
2+ and with the diphosphate moiety of the
donor substrate.
Most of the central domain of CEECAM1 failed to yield any
enzymatic activity when combined to GLT25D1. The kinetic
analysis of the CEECAM1-MidC construct showed that this
region was important for the rate of the galactosyltransferase
reaction. Considering the predicted GT-A fold of the GLT25
family proteins, this finding suggests that the central domain is
important to associate the two lobes of the active enzymes to
encompass the donor and acceptor substrates.
The C-terminal domain of the active GLT25D1 enzyme
includes two DXD motifs, which are missing in the corresponding
domain of the inactive CEECAM1 protein. Our mutagenesis
experiments showed that the first of these two DXD motifs is
required for the ColGalT activity of GLT25D1, whereas the
second one is dispensable. This fact suggests that the C-terminal
domain is also involved in the recognition of acceptor substrates
and that critical residues for this function are missing in the
CEECAM1 sequence. The importance of the C-terminal domain
in the recognition of the donor and acceptor substrates was
confirmed by the kinetic analysis performed on the partially active
chimeric construct CEECAM1-CterC.
Bacterial glycosyltransferases of the CAZY family GT25, such
as Lex2B b1,4-glucosyltransferase and LpsB b1,2-galactosyltrans-
ferase [26,27], share structural similarity with the C-terminal part
of GLT25D1 between amino acids 344 and 622. These bacterial
enzymes are involved in lipopolysaccharide biosynthesis and add
hexoses in the oligosaccharide extension. In spite of this structural
similarity as seen with the program PROMALS3D, the bacterial
Lex2B and LpsB glycosyltransferases also present differences to
GLT25D1 since they lack the first DXD motif and the RMQV
sequence, which are essential for the ColGalT activity.
The CEECAM1 protein was first described as a cerebral
adhesion protein [15], yet the CEECAM1 gene is widely
transcribed in the nervous system and in several secretory tissues
such as salivary glands, pancreas, liver and placenta [10]. The
presence of a potential ER retention signal at the end of the
Figure 5. ColGalT activity of GLT25D1 mutant constructs. The
enzymatic activity is expressed relatively to the activity of wildtype
GLT25D1. Values show the means and S.E.M. of at least four
independent assays. The expression of the mutant constructs is
confirmed by Western blotting performed in Sf9 cell lysate using an
anti-Flag antibody. The Mock sample shows the activity measured in Sf9
cells infected with an empty baculovirus.
doi:10.1371/journal.pone.0029390.g005
Figure 6. ColGalT activity of CEECAM1-CterB mutant con-
structs. The enzymatic activity is expressed relatively to the activity of
wildtype GLT25D1. Values show the means and S.E.M. of at least four
independent assays. The expression of the mutant constructs
CEECAM1-CterB[S461D] and CEECAM1-CterB[S461D][RMQV] is con-
firmed by Western blotting performed in Sf9 cell lysate using an anti-
Flag antibody. RMQV stands for the substitution Q471R-V472M-N473Q-
P474V.
doi:10.1371/journal.pone.0029390.g006
Figure 4. Multiple alignments of GLT25D1, GLT25D2 and CEECAM1. A) The portion of the central domain essential for ColGalT activity is
represented encompassing GLT25D1 amino acids 280 to 342. Sequences of GLT25D1 human (D1HU; Swiss-Prot:Q8NBJ5), bovine (D1BO; Swiss-
Prot:A5PK45), mouse (D1MO; Swiss-Prot:Q8K297), zebrafish (D1ZE; Swiss-Prot:A5PMF6), xenopus (D1XL; Swiss-Prot:A0JPH3) ; GLT25D2 human (D2HU;
Swiss-Prot:Q81IYK4), mouse (D2MO; Swiss-Prot:Q6NVG7), xenopus (D2XL; Swiss-Prot:Q5U483); CEECAM1 human (CEHU; Swiss-Prot:Q5T4B2), bovine
(CEBO; Swiss-Prot:A7MB73), mouse (CEMO; Swiss-Prot:A3KGW5), rat (CERA; Swiss-Prot:Q5U309) were aligned using ClustalW. Black squares represent
amino acids identical or strongly similar in all proteins, dark grey squares represent amino acids identical or similar in at least 10 proteins, light grey
squares represent amino acids identical or similar in at least 7 proteins. The amino acids conserved in GLT25D1 and GLT25D2 but not in CEECAM1 are
marked with a star at the top of the alignment. The residues P292 and D336 are marked with arrows. B) The alignment shows the portion of the C-
terminal domain essential for ColGalT activity corresponding to GLT25D1 amino acids 414 to 622. The origin of the sequences and the markings are
the same as in A.
doi:10.1371/journal.pone.0029390.g004
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the ER, like the active collagen galactosyltransferases GLT25D1
and GLT25D2. Our present study showed that the lack of
ColGalT activity of CEECAM1 is related to multiple changes in
the protein sequence when compared to GLT25D1 and
GLT25D2. However, we cannot exclude at this stage that
CEECAM1 does function as a glycosyltransferase that recognizes
substrates different from collagen. The presence of potential
CEECAM1 orthologous genes in all mammalian genomes would
argue against CEECAM1 as representing a pseudo-gene or being
the consequence of a late gene duplication event specifically found
in the human genome.
Taken together, our results provided insights on the functional
organization of the GLT25D1 ColGalT by showing that two
regions of the protein are essential for the enzymatic activity. Our
work also showed that the inactivity of CEECAM1 as a ColGalT
relies on multiple amino acid changes, thus suggesting different
substrate specificity or different biological activity. The determi-
nation of the exact structure of mammalian GLT25 proteins or of
homologous bacterial proteins by crystallization will clarify the
structural basis of the CEECAM1 functions.
Materials and Methods
Materials
Collagen type I from bovine Achilles tendon, UDP-Gal and the
anti-Flag M2 monoclonal antibody were from Sigma-Aldrich
(Buchs, Switzerland). UDP-[
14C]Gal was from GE Healthcare
(Glattbrugg, Switzerland). Restriction enzymes and DNA modify-
ing enzymes were from New England Biolabs (BioConcept,
Allschwil, Switzerland).
Generation of chimeric proteins GLT25D1-CEECAM1
Full length cDNA fragments were subcloned into pFastBac1-
Flag baculovirus transfer vector [28] to construct Flag-tagged
GLT25D1 and Flag-tagged CEECAM1 expression plasmids.
Chimeric GLT25D1-CEECAM1 constructs were created by
replacing parts of the GLT25D1 cDNA sequence by the
corresponding CEECAM1 sequence using restriction sites con-
served in both genes (Fig. S1). For the CEECAM1-Nter chimeric
protein, the restriction sites EcoRI at cDNA position 57 and NcoI
(position 796) were used. To create the CEECAM1-Mid and
CEECAM1-Cter chimeric proteins, GLT25D1 DNA was digested
with PspXI and XbaI, thereby releasing a 1698 bp fragment that
was subcloned into pBluescript-SKII (Agilent Technologies, Basel,
Switzerland) to create pBluescript-GLT25D1-short. Then, the
NcoI-Tth111I and Tth111I-XbaI fragments from GLT25D1 were
replaced respectively by the corresponding CEECAM1 sequence
using identical restriction sites, thus yielding the constructs
pBluescript-CEECAM1-Mid-short and pBluescript-CEECAM-
Cter-short. These two new constructs were digested by PspXI
and XbaI to subclone the 1698 bp fragments into pFastBac-
GLT25D1, yielding the constructs CEECAM1-Mid and CEE-
CAM1-Cter.
For the chimeric proteins CEECAM1-MidA/B/C/D and
CEECAM1-CterA/B/C/D/E, restriction sites were introduced
by PCR to generate silent mutations without impact on the amino
acid sequence. For chimeric proteins CEECAM1-MidA/B/C/D,
PCR was performed using pBluescript-GLT25D1-short as tem-
plate and forward and reverse primers listed in Table 2 and Figure
S1. These PCR products were digested and cloned back into
pBluescript-CEECAM1-Mid-short, previously linearized using the
same enzymes (Table 2, Fig. S1). The pBluescript-based constructs
were digested by PspXI and XbaI for cloning back into pFastBac-
GLT25D1 as described above, yielding the final constructs
CEECAM1-MidA/B/C/D.
For the chimeric protein CEECAM1-CterA, PCR was
performed on pBluescript-GLT25D1-short DNA using the
primers given in Table 2. The PCR product was digested by
MscI and XbaI (Fig. S2) and cloned back into pBluescript-
CEECAM1-Cter-short opened at the same restriction sites. For
chimeric proteins CEECAM-CterB/C/D/E, PCR was done on
pBluescript-CEECAM1-Cter-short DNA using the corresponding
forward and reverse primers listed in Table 2. After restriction
digestion (Fig. S2), CEECAM1 fragments were cloned back into
pBluescript-GLT25D1-short, previously digested by the same
enzymes. Finally, all engineered pBluescript DNA were digested
with PspXI and XbaI and introduced into pFastBac-GLT25D1 as
described above, yielding the constructs CEECAM1-CterA/B/C/
D/E. The integrity of the constructs generated by PCR was
verified by DNA sequencing (Microsynth, Balgach, Switzerland).
Mutagenesis
Site directed mutagenesis of GLT25D1 and chimeric
GLT25D1-CEECAM1 constructs was performed by Quick-
Change site-directed mutagenesis [29]. The corresponding
primers and DNA templates are shown in Table 3. The
introduction of the appropriate mutations was confirmed by
DNA sequencing (Microsynth). The mutant constructs are named
according to the amino acids substituted and their respective
position on the protein sequence where the start methionine of
GLT25D1 counts as position one.
ColGalT assays
Recombinant baculoviruses were produced in Spodoptera frugi-
perda Sf9 cells as described previously [30]. Galactosyltransferase
assays were performed as described by Schegg et al. [10]. Briefly,
2.10
6 infected Sf9 cells were lyzed in 50 mM TrisHCl pH 8,
150 mM NaCl, 1% Triton X100 and protease inhibitors
(Complete, Roche, Rotkreuz, Switzerland) for 15 min on ice.
Insoluble material was precipitated at 14,0006g for 20 min at 4uC.
Assays were performed using 10 ml of postnuclear supernatant,
Table 1. Kinetic parameters for chimeric constructs CEECAM1-MidC and CEECAM1-CterC.
UDP-Gal Collagen
Enzyme Km (mM) Vmax (pmol min
21)K m ( mg ml
21) Vmax (CPM min
21)
GLT25D1 29.9162.56 12.4561.09 5.760.9 235.13625.66
CEECAM1-MidC 20.3161.63 6.8660.45 5.0461.12 108.53629.95
CEECAM1-CterC 74.2965.56 11.261.4 13.461.75 259.27663.48
Values represent the average 6 S.E.M. of three independent experiments.
doi:10.1371/journal.pone.0029390.t001
Structure-Function Analysis of GLT25D1
PLoS ONE | www.plosone.org 7 December 2011 | Volume 6 | Issue 12 | e293905 mg/ml of denatured collagen type I from bovine Achilles
tendon, 60 mM UDP-Gal spiked with 50,000 cpm UDP-[
14C]Gal,
10 mM MnCl2, 20 mM NaCl, 50 mM morpholinepropanesulfo-
nic acid pH 7.4 and 1 mM DTT. Reactions were incubated for
3 h at 37uC then stopped by addition of 500 ml of 5%TCA/5%
phosphotungstic acid. The precipitated assay products were
applied on glass fiber filters (Whatman, Sigma-Aldrich), washed
with 10 ml of 50% ethanol, dried for 30 min and counted in a
scintillation b-counter (Packard).
Western Blotting
After determination of protein concentration, samples corre-
sponding to 10 mg proteins were denatured at 95uC, loaded on 8%
SDS-PAGE, and transferred to PVDF membranes (Millipore,
Zug, Switzerland). Flag proteins were detected using an anti-Flag
M2 monoclonal antibody (dilution 1:2,000) (Sigma-Aldrich), then
by a secondary antibody, anti-mouse peroxidase conjugate
(dilution 1:10,000) (Sigma-Aldrich), followed by detection using
SuperSignal West Pico chemiluminescent substrate (Thermo
Scientific, Lausanne, Switzerland).
Alignment and modeling of protein structure
Protein sequences corresponding to human GLT25D1 (Swiss-
Prot:Q8NBJ5), human GLT25D2 (Swiss-Prot:Q81IYK4) and
human CEECAM1 (Swiss-Prot:Q5T4B2) were used as input for
the PROMALS3D multiple sequence and structure alignment tool
(http://prodata.swmed.edu/ promals3d/promals3d.php) [18]. An
identity threshold of 0.6 was chosen and other settings were set as
default. Sequences were aligned according to predicted a-helices
and b-strands. Protein homology detection of the three proteins
Table 2. PCR primers used to generate chimeric GLT25D1-CEECAM1 proteins.
CEECAM1 chimeric construct Plasmid template Primer Oligonucleotide sequence (59-39) Restriction site
MidA pBluescript-GLT25D1-short For GCAGTTCCCATGGTGCACTC NcoI
Rev GCAACACGTGCATCTGAACCTCTGCCTGCTTGC PmlI
MidB pBluescript-GLT25D1-short For GCAGTTCCCATGGTGCACTC NcoI
Rev GCAAACTAGTACCTCCAGCTGCACATGCATG SpeI
MidC pBluescript-GLT25D1-short For GCAACACGTGTGCAACAAGGAGGAGTACG PmlI
Rev AGCCAGGCAGCATCTGGATC BamHI
MidD pBluescript-GLT25D1-short For GCAAACTAGTGAAGCACCCGCCCGCAGAGC SpeI
Rev AGCCAGGCAGCATCTGGATC BamHI
CterA pBluescript-GLT25D1-short For GCAATGGCCACGCAACCTGCATGCCTTC MscI
Rev GCGGCCGCTCTAGAGGCCAC XbaI
CterB pBluescript-CEECAM1-Cter-short For TGAGGCCGAGAGCTTCATGC NsiI
Rev GCAAGGCGCCCGCCAGACGCAGGGCATAG KasI
CterC pBluescript-CEECAM1-Cter-short For TGAGGCCGAGAGCTTCATGC NsiI
Rev GCAAGCTCAGGAAGCAGCCCACCTCGCC Bpu10I
CterD pBluescript-CEECAM1-Cter-short For GCAAGGCGCCCGCAAGCTGCTGGCCTCAC KasI
Rev CGGCCGCTCTAGAGTAGTGGCCTG XbaI
CterE pBluescript-CEECAM1-Cter-short For GCAACCTGAGCCATTACTCCATCTGGGAAGAGG Bpu10I
Rev GCAAGCTCAGGAAGCAGCCCACCTCGCC KasI
Plasmids used for PCR amplification are indicated for each constructs with the restriction sites used for cloning. Sequences are shown for the forward and reverse PCR
primers, respectively. Bases marked in bold represent positions changed to create new restriction sites. Underlined bases mark the restriction sites used for cloning and
dotted underlined bases show the partial restriction sites used for cloning. The BamHI restriction site used in MidC and MidD constructs is present at the 39-end of the
PCR product and not in the PCR primer.
doi:10.1371/journal.pone.0029390.t002
Table 3. Sense strand oligonucleotides used for site-directed mutagenesis.
Plasmid template Mutations Oligonucleotide sequence (59-39)
GLT25D1 D166A-D168A CATCCTGTTTGTAGCGGCCGCCAACCTGATCCTCAACCC
GLT25D1 P292N GGAGTACGGATTCTTGAACGTTCCATTGCGCGCCCACAGC
GLT25D1 D336S CCCACCAAGACACCGAGCAAGATGGGCTTCG
GLT25D1 D461A-D463A GGAGGGCCTGGCCTGGGCCCTCATCTATGTGG
GLT25D1 D585A-D587A CGTCAAGACCGCCTGGGCCCGCGCCAAGTCC
CEECAM1-CterB S461D GGAGGCAGAGAAACTGGATTGGGACCTGATCTACC
CEECAM1-CterB[S461D] Q471R-V472M-N473Q-P474V GATCTACCTCGGACGGAAGCGCATGCAGGTTGAGAAGGAGACGGCCGTGG
Sequences show the sense strand oligonucleotides of each complementary pair of primers used for site-directed mutagenesis. Underlined bases mark the introduced
mutations.
doi:10.1371/journal.pone.0029390.t003
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database (http://toolkit.tuebingen.mpg.de/hhpred) [19]. Multiple
sequence alignment was done using ClustalW2 program (http://
www.ebi.ac.uk/Tools /msa/clustalw2/) [31].
Supporting Information
Figure S1 Schematic representation of the PCR frag-
ments used to generate chimeric CEECAM1-MidA/B/
C/D constructs. Segments of GLT25D1 and CEECAM1 are
marked in light grey and dark grey, respectively. The full length
GLT25D1 cDNA is represented at the top with the relative
positions of the restriction sites used for cloning. The partial region
of pBluescript-CEECAM1-Mid-short with the corresponding
restriction sites is shown below with the PCR products and
primers (arrows) including restriction sites used for cloning.
(TIF)
Figure S2 Schematic representation of the PCR frag-
ments used to generate chimeric CEECAM1-CterA/B/
C/D/E constructs. The top panel shows the full length
GLT25D1 cDNA with the restriction sites used for cloning. Below
the C-terminal domain of CEECAM1-Cter-short and the CterA
construct are represented as in supplemental figure S1. The
bottom panel shows the C-terminal domain of GLT25D1 with the
relative positions of the restriction sites used for cloning. Below, the
CterB/C/D/E constructs are represented as in supplemental
figure S1.
(TIF)
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